Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Unveiling long COVID: new study explores symptoms and strain variations

Unveiling long COVID: new study explores symptoms and strain variations

Did patterns of US ED visits and mental health–related ED visits change during the COVID-19 pandemic?

Did patterns of US ED visits and mental health–related ED visits change during the COVID-19 pandemic?

Boosted immunity: Delta and Omicron-BA.1 infections enhance protection in vaccinated patients

Boosted immunity: Delta and Omicron-BA.1 infections enhance protection in vaccinated patients

Unveiling the key defender: PLSCR1 identified as a potent anti-SARS-CoV-2 factor in COVID-19 immunity

Unveiling the key defender: PLSCR1 identified as a potent anti-SARS-CoV-2 factor in COVID-19 immunity

Novel approach: intranasal vaccination strategy targets Omicron COVID-19 variants

Novel approach: intranasal vaccination strategy targets Omicron COVID-19 variants

Investigating the role of T-cell immunity in long COVID

Investigating the role of T-cell immunity in long COVID

pAQ monitor: innovative device provides real-time surveillance of SARS-CoV-2 aerosols

pAQ monitor: innovative device provides real-time surveillance of SARS-CoV-2 aerosols

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

COVID-19 excess mortality measured by the Global Health Security Index

COVID-19 excess mortality measured by the Global Health Security Index

Does previous antibiotic treatment affect COVID-19 severity?

Does previous antibiotic treatment affect COVID-19 severity?

How does SARS-CoV-2 affect the placenta during pregnancy?

How does SARS-CoV-2 affect the placenta during pregnancy?

Self-reported long COVID symptoms not identified in diagnostic tests

Self-reported long COVID symptoms not identified in diagnostic tests

Could neutralizing SARS-CoV-2 monoclonal antibodies pre-exposure prophylaxis be cost-effective in a population at risk for severe COVID-19?

Could neutralizing SARS-CoV-2 monoclonal antibodies pre-exposure prophylaxis be cost-effective in a population at risk for severe COVID-19?

mAb-based bELISA developed to detect SARS-CoV-2 antibodies in a broad spectrum of animal species

mAb-based bELISA developed to detect SARS-CoV-2 antibodies in a broad spectrum of animal species

Researchers identify glycolipid that blocks infection with SARS-CoV-2 and RSV

Researchers identify glycolipid that blocks infection with SARS-CoV-2 and RSV

The causative role of age-associated pre-existing senescent cells on COVID-19 severity

The causative role of age-associated pre-existing senescent cells on COVID-19 severity

Prolonged T-cell response during severe COVID-19 does not contribute to long COVID

Prolonged T-cell response during severe COVID-19 does not contribute to long COVID

Alarming pediatric hospital admissions linked to COVID-19 in England

Alarming pediatric hospital admissions linked to COVID-19 in England

The vital role of smartphone apps during the COVID-19 pandemic

The vital role of smartphone apps during the COVID-19 pandemic

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.